MXCT · Forms 3, 4, 5
Insider trades at MAXCYTE, INC.
No open-market insider buys or sells at MAXCYTE, INC. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for MAXCYTE, INC. (MXCT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for MAXCYTE, INC. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| John Joseph Johnston | Director | Award | 30,421 | Form 4 | |||
| Rekha Hemrajani | Director | Award | 30,421 | Form 4 | |||
| Stanley C Erck | Director | Award | 30,421 | Form 4 | |||
| Richard Douglas | Director | Award | 30,421 | Form 4 | |||
| Cynthia Collins | Director | Award | 30,421 | Form 4 | |||
| William W Brooke | Director | Award | 30,421 | Form 4 | |||
| Patrick J Balthrop | Director | Award | 30,421 | Form 4 | |||
| Yasir B. Al-Wakeel | Director | Award | 30,421 | Form 4 | |||
| Parmeet Ahuja | Chief Financial Officer | Award | 187,500 | Form 4 | |||
| Parmeet Ahuja | Chief Financial Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.